Brodsky & Smith is investigating four proposed mergers involving Werewolf Therapeutics, Beazer Homes, Lantheus Holdings and MarketAxess for potential breaches of fiduciary duties. Werewolf would be acquired by Ambros Therapeutics, Beazer by Dream Finders Homes for $33.50 per share, Lantheus by Curium for $102.50 per share plus contingent value rights worth up to $12, and MarketAxess by Intercontinental Exchange for $167 per share. The firm is examining whether the companies’ boards conducted fair processes and whether the proposed transactions provide fair value to shareholders. Investors may contact the firm at no cost or financial obligation.